Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07439302
Eligibility Criteria:
Inclusion Criteria:
1. Adults (over 18 years of age)
2. Written consent from the patient to participate in the clinical study
3. Diagnosed with grade 2-4 glioma with IDH1/2 mutation
4. Plan to initiate new systemic treatment for glioma (chemotherapy, targeted therapy, or other investigational antitumor systemic agent)
5. Candidate for ePRO monitoring using Resilience PRO medical device according to local investigator decision
6. Social security coverage
Exclusion Criteria:
1. Severe language impairment
2. Cognitive deficit preventing the understanding of essential elements for questionnaires
3. Patient under guardianship or curatorship
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07439302
Study Brief:
Protocol Section:
NCT07439302